MDM2 and plasma cell myeloma: In addition, the first-generation USP7 inhibitor P5091 induces apoptosis in multiple myeloma cells by promoting ubiquitination of MDM2 and MDMX, which in turn activates the p53 pathway and ultimately induces apoptosis.